Insider Trading Activity FibroGen, Inc (NASDAQ:FGEN) – Director Sold 2,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For FibroGen, Inc (NASDAQ:FGEN)

Kalevi Kurkijarvi , Director of FibroGen, Inc (NASDAQ:FGEN) reportedly Sold 2,000 shares of the company’s stock at an average price of 33.45 for a total transaction amount of $66,900.00 SEC Form

Insider Trading History For FibroGen, Inc (NASDAQ:FGEN)

  • On 6/25/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $23.57 per share and the total transaction amounting to $636,390.00.View SEC Filing
  • On 7/6/2015 K Peony Yu, VP, sold 5,381 with an average share price of $22.69 per share and the total transaction amounting to $122,094.89.View SEC Filing
  • On 7/9/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $22.11 per share and the total transaction amounting to $596,970.00.View SEC Filing
  • On 7/20/2015 Pat Cotroneo, CFO, sold 7,881 with an average share price of $23.47 per share and the total transaction amounting to $184,967.07.View SEC Filing
  • On 7/20/2015 Frank H Md Valone, Insider, sold 1,000 with an average share price of $23.70 per share and the total transaction amounting to $23,700.00.View SEC Filing
  • On 7/23/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $24.71 per share and the total transaction amounting to $667,170.00.View SEC Filing
  • On 9/1/2015 Frank H. Md Valone, insider, sold 10,000 with an average share price of $23.58 per share and the total transaction amounting to $235,800.00.View SEC Filing

    • Analyst Ratings For FibroGen, Inc (NASDAQ:FGEN)
    These are 7 Buy Ratings .
    The current consensus rating for FibroGen, Inc (NASDAQ:FGEN) is Buy (Score: 3.00) with a consensus target price of $45.00 , a potential (29.87% upside)

    Analyst Ratings History For FibroGen, Inc (NASDAQ:FGEN)

    • On 9/23/2015 Lake Street Capital Initiated Coverage of rating Hold with a price target of $25.00 with a price target of $34.00 to $31.00
    • On 8/9/2016 Credit Suisse Group Reiterated Rating Buy with a price target of $37.00
    • On 11/9/2016 Leerink Swann Reiterated Rating Buy with a price target of $52.00
    • On 1/18/2017 Royal Bank Of Canada Reiterated Rating Buy
    • On 6/22/2017 Stifel Nicolaus Reiterated Rating Buy with a price target of $32.00 to $38.00
    • On 6/26/2017 William Blair Reiterated Rating Outperform

    Recent Trading Activity for FibroGen, Inc (NASDAQ:FGEN)
    Shares of FibroGen, Inc closed the previous trading session at 34.65 down -0.35 -1.00% with 264,336 shares trading hands.